Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection
Abstract Background Colistin has been used for therapy of carbapenem-resistant Gram-negative infections in Thailand, especially carbapenem-resistant A. baumannii and P. aeruginosa, for more than 10 years. However, the prevalence of colistin-resistant A. baumannii or P. aeruginosa is still less than...
Main Authors: | W. Wangchinda, N. Pati, N. Maknakhon, C. Seenama, S. Tiengrim, V. Thamlikitkul |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-018-0375-4 |
Similar Items
-
Résistance à la colistine chez Klebsiella pneumoniae
by: Herold Manuelli, Marine
Published: (2018) -
The Occurence of Colistin-Resistant Hypervirulent Klebsiellapneumoniae in China
by: Yang Lu, et al.
Published: (2018-10-01) -
MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258
by: Béla Kocsis, et al.
Published: (2017-10-01) -
Colistin for multidrug-resistant Acinetobacter baumannii from Thailand
by: Srisupha-Olarn, Warunee
Published: (2011) -
Treatment Options for Colistin Resistant <i>Klebsiella pneumoniae</i>: Present and Future
by: Nicola Petrosillo, et al.
Published: (2019-06-01)